Harvard Medical School/MIT Health Sciences and Technology, M.D.
Brigham and Women's Hospital, residency in internal medicine
Dana-Farber/Partners CancerCare, fellowship in hematology and oncology
Broad Institute, postdoctoral fellowship
Zuzana Tothova, MD PhD
Dr. Tothova is an Investigator in the Department of Medical Oncology and the Division of Hematologic Neoplasia at the Dana-Farber Cancer Institute, Instructor in Medicine at Harvard Medical School, Associate Member of the Broad Institute, and principal faculty in the Harvard Stem Cell Institute. Dr. Tothova received her B.A. in Biology and Chemistry from Williams College, where she first developed her interest in cancer biology while studying the mechanisms of exit from mitosis in yeast in Dr. Wendy Raymond’s laboratory. She subsequently received a doctorate in Genetics from Harvard University for her work on FoxO transcription factors in self-renewal mechanisms of hematopoietic stem cells in Dr. Gary Gilliland’s laboratory, and an M.D. from Harvard Medical School/MIT in the Health Sciences and Technology program. She completed residency training in internal medicine at the Brigham and Women's Hospital and fellowship training in adult hematology and oncology at the Dana-Farber Cancer Institute and MGH Cancer Center. Dr. Tothova carried out her postdoctoral work in Dr. Benjamin Ebert’s laboratory at the Broad Institute where she studied mechanisms of cohesin mutations in myelodysplastic syndrome and acute myeloid leukemia, and where she also developed new models of myeloid malignancies using multiplex CRISPR engineering of primary human hematopoietic stem cells. She is a recipient of multiple career development awards from the American Society of Hematology, Leukemia and Lymphoma Society, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Burroughs Wellcome Fund, and the National Institutes of Health. Outside of the lab, she is an avid foodie, skier, and an outdoors fan, and enjoys art and classical music.